GEN Exclusives

More »

GEN News Highlights

Back to Item »

FDA Committee Unanimously Supports Boehringer Ingelheim’s Stroke-Prevention Drug in Atrial Fibrillation

Dabigatran etexilate, an oral direct thrombin inhibitor, does not require INR monitoring, dose adjustments, or food restrictions.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?